Profile
William J.
Slichenmyer worked as a Principal at Bristol Myers Squibb Co. and Idera Pharmaceuticals, Inc. He was the Global Head-Oncology Clinical Development at Pfizer Inc. for a brief period in 2007.
He served as the Chief Medical Officer & Senior Vice President at Merrimack Pharmaceuticals, Inc. from 2007 to 2009 and as the Chief Medical Officer at AVEO Pharmaceuticals, Inc. from 2009 to 2014.
Slichenmyer received his undergraduate and doctorate degrees from Case Western Reserve University and his graduate degree from The Johns Hopkins University.
Former positions of William J. Slichenmyer
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2014-04-29 |
| MERRIMACK PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2009-08-31 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of William J. Slichenmyer
| Case Western Reserve University | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- William J. Slichenmyer